Showing options holdings,
see here
for stock holdings
Deerfield Management Company, L.P. (Series C) Q3 2020 Portfolio
Deerfield Management Company, L.P. (Series C) didn't report any options holdings as of Q3 2020.
Check stock holdings.
Filing 2020 Q3 - Restatement compared to 2020 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
James E. Flynn
Managing Member
New York, New York
30 Dec 2020
This amendment is being filed to correct the market value for Windtree Therapeutics Inc. and the total market value of 13F securities held by the Institutional Investment Manager.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.